No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CLPT ClearPoint Neuro
- 7.210
- +0.140+1.98%
Close Jul 22 16:00 ET
- 7.040
- -0.170-2.36%
Post 16:23 ET
197.70MMarket Cap-8686P/E (TTM)
7.210High6.930Low87.60KVolume7.080Open7.070Pre Close622.20KTurnover0.35%Turnover RatioLossP/E (Static)27.42MShares7.97052wk High5.72P/B180.67MFloat Cap4.05052wk Low--Dividend TTM25.06MShs Float31.290Historical High--Div YieldTTM3.96%Amplitude2.860Historical Low7.102Avg Price1Lot Size
Post-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024
ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) P/S Is Still On The Mark Following 33% Share Price Bounce
ClearPoint Neuro, Inc. (NASDAQ:CLPT) shareholders have had their patience rewarded with a 33% share price jump in the last month. Looking further back, the 12% rise over the last twelve months isn'
Strength Seen in ClearPoint Neuro (CLPT): Can Its 16.9% Jump Turn Into More Strength?
Clinical Laserthermia Systems Gets Additional SEK7.5 Million Orders From ClearPoint Neuro
Clinical Laserthermia Systems (CLS-B.ST) secured additional orders worth 7.5 million kronor from ClearPoint Neuro for their joint product. The Swedish medical equipment company said Thursday it will d
Express News | Aspen Neuroscience Uses MRI-Guided ClearPoint Navigation System For Patients Enrolled In ASPIRO Phase 1/2a Clinical Trial For Transplantation Of Dopaminergic Neuron Precursor Cells In Patients With Parkinson's Disease
Express News | Clearpoint Neuro Congratulates Partner Aspen Neuroscience on Use of the Clearpoint® Navigation System for All Enrolled Patients in Aspiro Clinical Trial
Comments
Given the ongoing'higher for longer' trend affecting small-cap names.
Here are the companies I'm watching to potentially initiate a position in my small-cap portfolio:
![]()
1. $Enovix(ENVX.US$| Advanced Lithium-Ion Battery
Focuses on the development and manufacturing of advanced silicon-anode lithium-ion batteries that enhance the energy density and safety of portable electronics and electric vehicles.
![]()
2. $AST SpaceMobile(ASTS.US$| Satellite Communications
Provides spa...
Here are the companies I'm watching to potentially initiate a position in my small-cap portfolio:
Focuses on the development and manufacturing of advanced silicon-anode lithium-ion batteries that enhance the energy density and safety of portable electronics and electric vehicles.
Provides spa...
8
$ClearPoint Neuro(CLPT.US$
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial
$ClearPoint Neuro(CLPT.US$
ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System
ClearPoint Neuro announced the full market release of its SmartFrame OR platform and ClearPoint Prism Neuro Laser Therapy System at the 2024 ASSFN meeting in Nashville from June 1-4.
The SmartFrame OR aims to expand Deep Brain Stimulation (DBS) to more hospitals, making it accessible to more patients. Dr. Kim Burchiel noted that DBS is effective for Parki...
ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System
ClearPoint Neuro announced the full market release of its SmartFrame OR platform and ClearPoint Prism Neuro Laser Therapy System at the 2024 ASSFN meeting in Nashville from June 1-4.
The SmartFrame OR aims to expand Deep Brain Stimulation (DBS) to more hospitals, making it accessible to more patients. Dr. Kim Burchiel noted that DBS is effective for Parki...
$ClearPoint Neuro(CLPT.US$
NEWS
ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore
SOLANA BEACH, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it will present novel research and exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting to be hel...
NEWS
ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore
SOLANA BEACH, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it will present novel research and exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting to be hel...
$ClearPoint Neuro(CLPT.US$ Damn just no volume! Guess FDA ok on stuff for bones dont rate as great as a pill or a shot the deal with the most rare of diseases of all to fight! OVERWEIGHT! Hehehe![]()
2
3
and I’m not saying lifestyle is the only cause of obesity but it is the MAJOR factor.Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
